v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current Assets:    
Cash $ 8,356,834 $ 33,785
Accounts receivable, net 797,422 38,704
Prepaid expenses and other current assets 117,085 28,072
Total Current Assets 9,271,341 100,561
Intangible assets, net 1,357,726 83,333
Property and equipment, net 8,088 4,549
Deferred offering costs 10,000 285,196
Total Assets 10,647,155 473,639
Current Liabilities:    
Accounts payable - suppliers 319,484 785,180
Accounts payable - trade 1,531,084 867,554
Accrued expenses and other current liabilities 766,621 478,674
Accrued interest 3,001 117,912
Accrued interest - related parties 0 4,204
Due to related party 29,000 29,000
Notes payable, current portion 136,242 113,967
Convertible notes payable, current portion, net of discount of $0 and $630,994 as of September 30, 2020 and December 31, 2019, respectively   2,569,006
Convertible notes payable - related parties, current portion, net of discount of $0 and $281,701 as of September 30, 2020 and December 31, 2019, respectively   548,799
Total Current Liabilities 2,785,432 5,514,296
Notes payable, non-current portion 269,848  
Total Liabilities 3,055,280 5,514,296
Commitments and contingencies (Note 8)
Stockholders' Equity (Deficiency):    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of September 30, 2020 and December 31, 2019
Common stock, $0.00001 par value; 95,000,000 shares authorized; 7,661,300 and 3,601,521 shares issued and outstanding as of September 30, 2020 and December 31, 2019 77 36
Additional paid-in capital 21,723,133 3,362,724
Accumulated deficit (14,131,335) (8,403,417)
Total Stockholders' Equity (Deficiency) 7,591,875 (5,040,657)
Total Liabilities and Stockholders' Equity (Deficiency) $ 10,647,155 $ 473,639

Source